Table 2.
Objective outcomes for HoLEP vs OP.
| Variable, mean (SD) | Naspro et al. [12] | Salonia et al. [13] | Kuntz et al. [16] |
|---|---|---|---|
| Qmax, mL/s | |||
| Before procedure | 7.83 (3.42) vs 8.32 (2.37) | 8.9 (4.2) vs 8.4 (2.4) | 3.8 (3.6) vs 3.6 (3.8) |
| At 12-month follow-up | 22.32 (3.8) vs 24.21 (6.49) | NR | 27.4 (9.7) vs 28.3 (7.5) |
| At 24-month follow-up | 19.19 (6.3) vs 20.11 (8.8) | NR | 26.7 (8.3) vs 27.4 (6.8) |
| At ⩾ 36-month follow-up | NR | NR | 27 (9.8) vs 25.3 (6.8) |
| PVR, mL | |||
| Before procedure | NR | 87.4 (83.5) vs 106.3 (71.8) | 280 (273) vs 292 (191) |
| At 12-month follow-up | NR | NR | 5.8 (16.7) vs 6.4 (12.3) |
| At 24-month follow-up | NR | NR | 1.7 (6.5) vs 2.4 (6.7) |
| At ⩾ 36-month follow-up | NR | NR | 6.1 (12.1) vs 4.4 (10.5) |